Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-07CALC3Form 3 Filing for CalciMedica, Inc.MEDIUM
This filing details the initial ownership of securities by Evgeny Zaytsev, a director at CalciMedica, Inc. (CALC). The securities are held through Bering Partners II, L.P. (Bering II), where Mr. Zaytsev, along with Philip Sawyer, are managing members of the general partner, Bering Partners II GP, L.L.C. (Bering II GP)....
Nano CapBiotechnology
2026-07-07ETHZ3FORUM MARKETS Inc - Form 3 FilingMEDIUM
This filing details the beneficial ownership of Brian James Pemble in FORUM MARKETS Inc. As of June 29, 2026, Mr. Pemble directly owns 78,500 shares of Common Stock. Additionally, he indirectly owns shares through various accounts: 371,303 shares in a 401(k) account, 274,844 shares in another 401(k) account, and 62,067...
Micro CapBiotechnology
2026-07-07OGEN3Form 3 Filing for Spencer John, CFO of ORAGENICS INCMEDIUM
This filing reports initial ownership of securities by Spencer John, Chief Financial Officer of ORAGENICS INC. Mr. John was granted 10,000 employee stock options with an exercise price of $0.93 per share, exercisable through December 11, 2035. One-third of these options vest one year after the grant date, with the rema...
Nano CapBiotechnology
2026-07-07FORUM MARKETS Inc3FORUM MARKETS Inc - Form 3 FilingDuplicateMEDIUM
This filing details the beneficial ownership of Brian James Pemble in FORUM MARKETS Inc. As of June 29, 2026, Mr. Pemble directly owns 78,500 shares of Common Stock. Additionally, he indirectly owns shares through various accounts: 371,303 shares in a 401(k) account, 274,844 shares in another 401(k) account, and 62,067...
Micro CapBiotechnology
2026-07-07PLUR3Insider Ownership Filing for Pluri Inc.
This filing details the ownership of Pluri Inc. (PLUR) common stock by reporting owner Doron Shorrer. Mr. Shorrer, who is a director at Pluri Inc., directly owns 6,659 shares of common stock. Additionally, he indirectly owns 6,969 shares through Shorrer International Ltd. The filing is based on the period of report end...
Nano CapBiotechnology
2026-07-07Pluri Inc.3Insider Ownership Filing for Pluri Inc.Duplicate
This filing details the ownership of Pluri Inc. (PLUR) common stock by reporting owner Doron Shorrer. Mr. Shorrer, who is a director at Pluri Inc., directly owns 6,659 shares of common stock. Additionally, he indirectly owns 6,969 shares through Shorrer International Ltd. The filing is based on the period of report end...
Nano CapBiotechnology
2026-07-07ORAGENICS INC3Form 3 Filing for Spencer John, CFO of ORAGENICS INCDuplicateMEDIUM
This filing reports initial ownership of securities by Spencer John, Chief Financial Officer of ORAGENICS INC. Mr. John was granted 10,000 employee stock options with an exercise price of $0.93 per share, exercisable through December 11, 2035. One-third of these options vest one year after the grant date, with the rema...
Nano CapBiotechnology
Sponsored
2026-07-07CalciMedica, Inc.3Form 3 Filing for CalciMedica, Inc.DuplicateMEDIUM
This filing details the initial ownership of securities by Evgeny Zaytsev, a director at CalciMedica, Inc. (CALC). The securities are held through Bering Partners II, L.P. (Bering II), where Mr. Zaytsev, along with Philip Sawyer, are managing members of the general partner, Bering Partners II GP, L.L.C. (Bering II GP)....
Nano CapBiotechnology
2026-07-06ABCL3Initial Statement of Beneficial Ownership of Securities
This filing reports an initial statement of beneficial ownership of securities for Lynn Seely, a director at AbCellera Biologics Inc. The filing, dated June 30, 2026, indicates that Seely has no direct or indirect ownership of securities as of the reporting date. The document was filed by Tryn Stimart, acting as attorn...
Small CapBiotechnology